Skip to main content
  • AACR Publications
    • Blood Cancer Discovery
    • Cancer Discovery
    • Cancer Epidemiology, Biomarkers & Prevention
    • Cancer Immunology Research
    • Cancer Prevention Research
    • Cancer Research
    • Clinical Cancer Research
    • Molecular Cancer Research
    • Molecular Cancer Therapeutics

AACR logo

  • Register
  • Log in
  • My Cart
Advertisement

Main menu

  • Home
  • About
    • The Journal
    • AACR Journals
    • Journal Sections
    • Subscriptions
    • Reviewing
    • Permissions and Reprints
  • Articles
    • OnlineFirst
    • Current Issue
    • Past Issues
    • Collections
      • COVID-19 & Cancer Resource Center
      • Clinical Trials
      • Immuno-oncology
      • Editors' Picks
      • "Best of" Collection
  • For Authors
    • Information for Authors
    • Author Services
    • Best of: Author Profiles
    • Submit
  • Alerts
    • Table of Contents
    • Editors' Picks
    • OnlineFirst
    • Citation
    • Author/Keyword
    • RSS Feeds
    • My Alert Summary & Preferences
  • News
    • Cancer Discovery News
    • Journal Press Releases
  • COVID-19
  • Webinars
  • 10th Anniversary
  • Search More

    Advanced Search

  • AACR Publications
    • Blood Cancer Discovery
    • Cancer Discovery
    • Cancer Epidemiology, Biomarkers & Prevention
    • Cancer Immunology Research
    • Cancer Prevention Research
    • Cancer Research
    • Clinical Cancer Research
    • Molecular Cancer Research
    • Molecular Cancer Therapeutics

User menu

  • Register
  • Log in
  • My Cart

Search

  • Advanced search
Cancer Discovery
Cancer Discovery
  • Home
  • About
    • The Journal
    • AACR Journals
    • Journal Sections
    • Subscriptions
    • Reviewing
    • Permissions and Reprints
  • Articles
    • OnlineFirst
    • Current Issue
    • Past Issues
    • Collections
      • COVID-19 & Cancer Resource Center
      • Clinical Trials
      • Immuno-oncology
      • Editors' Picks
      • "Best of" Collection
  • For Authors
    • Information for Authors
    • Author Services
    • Best of: Author Profiles
    • Submit
  • Alerts
    • Table of Contents
    • Editors' Picks
    • OnlineFirst
    • Citation
    • Author/Keyword
    • RSS Feeds
    • My Alert Summary & Preferences
  • News
    • Cancer Discovery News
    • Journal Press Releases
  • COVID-19
  • Webinars
  • 10th Anniversary
  • Search More

    Advanced Search

Research Watch

Focal Amplification of Super-Enhancers Upregulates Oncogenic Drivers

DOI: 10.1158/2159-8290.CD-RW2015-239 Published February 2016
  • Article
  • Figures & Data
  • Info & Metrics
  • PDF
Loading
  • Major finding: Super-enhancer copy-number gain increases expression of cancer-related genes.

  • Concept: Amplification of the identified super-enhancers leads to upregulation of MYC, KLF5, USP12, and PARD6B.

  • Impact: Lineage-specific super-enhancer amplification may promote tumorigenesis in multiple cancer types.

Figure1

Copy-number alterations are important drivers of cancer; however, the specific mechanisms by which amplifications and deletions in noncoding regions promote cancer are not understood. By analyzing The Cancer Genome Atlas copy-number data and corresponding acetylated histone H3 lysine 27 (H3K27ac) chromatin immunoprecipitation sequencing (ChIP-seq) data across 29 tumor types, Zhang, Choi, Francis, and colleagues identified 55 focally amplified noncoding regions, 6 of which were tissue-specific amplifications in super-enhancer regions. In head and neck squamous cell carcinoma, KLF5 was upregulated by amplification of a cluster of 3 super-enhancers marked by H3K27ac. Esophageal carcinomas harbored amplification of a distinct KLF5 super-enhancer, further supporting super-enhancer amplification as a mechanism to upregulate putative oncogenes including KLF5. Focal amplification of USP12 and PARD6B super-enhancers occurred in colorectal carcinoma and liver hepatocellular carcinoma, respectively. In addition, two distinct noncoding focal amplifications located 3′ of the MYC gene and associated with increased MYC expression were found in lung adenocarcinoma (MYC-LASE) and uterine corpus endometrial carcinoma (MYC-ECSE), and were in different regions than the previously identified MYC super-enhancers in T-cell acute lymphoblastic leukemia and acute myeloid leukemia. H3K27ac and p300 ChIP-seq confirmed that the MYC-LASE and MYC-ECSE super-enhancers were active only in cell lines of the respective tumor type, and chromosome conformation capture demonstrated that both super-enhancers physically interacted with the MYC promoter only in cells in which the super-enhancers were active. The active enhancer region of MYC-LASE was mapped to a 148bp region with the strongest activity in reporter assays, which required binding by the transcription factors NFE2L2 and CEBPβ for optimal activation. CRISPR/Cas9–mediated repression or deletion of the MYC-LASE active enhancer region reduced MYC expression and anchorage-independent growth. These findings suggest that amplification of super-enhancers can upregulate oncogenes in a lineage-specific manner to promote tumorigenesis.

Zhang X, Choi PS, Francis JM, Imielinski M, Watanabe H, Cherniack AD, et al. Identification of focally amplified lineage-specific super-enhancers in human epithelial cancers. Nat Genet 2015 Dec 14 [Epub ahead of print].

Notes

Note: Research Watch is written by Cancer Discovery editorial staff. Readers are encouraged to consult the original articles for full details. For more Research Watch, visit Cancer Discovery online at http://cancerdiscovery.aacrjournals.org/content/early/by/section.

  • ©2016 American Association for Cancer Research.
PreviousNext
Back to top
Cancer Discovery: 6 (2)
February 2016
Volume 6, Issue 2
  • Table of Contents
  • Table of Contents (PDF)
  • About the Cover

Sign up for alerts

View this article with LENS

Open full page PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for sharing this Cancer Discovery article.

NOTE: We request your email address only to inform the recipient that it was you who recommended this article, and that it is not junk mail. We do not retain these email addresses.

Enter multiple addresses on separate lines or separate them with commas.
Focal Amplification of Super-Enhancers Upregulates Oncogenic Drivers
(Your Name) has forwarded a page to you from Cancer Discovery
(Your Name) thought you would be interested in this article in Cancer Discovery.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
Focal Amplification of Super-Enhancers Upregulates Oncogenic Drivers
Cancer Discov February 1 2016 (6) (2) 118; DOI: 10.1158/2159-8290.CD-RW2015-239

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
Focal Amplification of Super-Enhancers Upregulates Oncogenic Drivers
Cancer Discov February 1 2016 (6) (2) 118; DOI: 10.1158/2159-8290.CD-RW2015-239
del.icio.us logo Digg logo Reddit logo Twitter logo CiteULike logo Facebook logo Google logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
    • Abstract
    • Notes
  • Figures & Data
  • Info & Metrics
  • PDF
Advertisement

Related Articles

Cited By...

More in this TOC Section

Research Watch

  • Structures Identify Selpercatinib and Pralsetinib Resistance Mechanisms
  • Cryo-EM Structures Reveal Mechanism of Anticancer MCT1 Inhibitors
  • Computational Tool Characterizes Previously Unidentified Tumor Subtypes
Show more Research Watch

Epigenetics

  • Computational Tool Characterizes Previously Unidentified Tumor Subtypes
  • FBXO44 Silences Repetitive Elements during DNA Replication in Cancer
  • H1 Loss Increases Accessibility of Stemness Genes to Drive Lymphoma
Show more Epigenetics
  • Home
  • Alerts
  • Feedback
  • Privacy Policy
Facebook   Twitter   LinkedIn   YouTube   RSS

Articles

  • OnlineFirst
  • Current Issue
  • Past Issues

Info For

  • Authors
  • Subscribers
  • Advertisers
  • Librarians

About Cancer Discovery

  • About the Journal
  • Editors
  • Journal Sections
  • Permissions
  • Submit a Manuscript
AACR logo

Copyright © 2021 by the American Association for Cancer Research.

Cancer Discovery
eISSN: 2159-8290
ISSN: 2159-8274

Advertisement